Full title: SarcoSIGHT: A Randomised-Control Trial of Fluorescence Guided Sarcoma Surgery Versus the Standard of Care
Age: Any
Phase: Other
Locations:
Newcastle – The Newcastle upon Tyne Hospitals NHS Foundation Trust (lead centre)
Swansea – Swansea Bay University Health Board
Swansea – Swansea Bay University Health Board
Brief summary:
A prospective, 2-arm, open-label, UK multi-centre, randomised control trial comparing fluorescence-guided surgery (FGS) with indocyanine green (ICG) to standard care (no fluorescence guidance) to determine the effect on the unexpected positive margin rate (UPM) in patients with sarcoma.
The aims of the trial are to find out:
- whether fluorescence guided surgery is better than standard surgery to remove the sarcoma with a clear margin
- whether there are fewer complications with fluorescence guided surgery
- how both surgeries affect quality of life
To find out more about this trial and whether you could take part, talk to your clinical team.
